Hydrofarm reveals Peters' retirement and announces Yetter's appointment to the board.
Board Appointment: Chris Yetter has been appointed to the Board of Directors and the Compensation Committee of Hydrofarm, effective October 1, 2025.
Board Resignation: Susan Peters will retire and resign from the Board of Directors on the same date, with no disagreements cited regarding the company's operations or policies.
Get Free Real-Time Notifications for Any Stock
Analyst Views on HYFM
About HYFM
About the author
Calavo Growers Reveals Change in Leadership
Leadership Transition: Lee E. Cole will retire as President and CEO of Calavo Growers on December 8, 2025, after four decades of leadership, with B. John Lindeman appointed as his successor.
Acknowledgment of Contributions: The Board of Directors expressed gratitude for Cole's leadership, highlighting his role in strengthening the company's operational foundation and expanding its global reach.
Lindeman's Background: B. John Lindeman, who previously served as CFO of Calavo and has extensive industry experience, is expected to drive growth and create sustainable value for shareholders.
Ongoing Strategic Review: Calavo is currently evaluating strategic alternatives following a non-binding acquisition proposal received in June 2025, with no further comments planned until a specific development occurs.
GrowGeneration Reports Q3 Earnings Exceed Expectations, Revenues Decline 6% Year-Over-Year
GrowGeneration Corp. Q3 2025 Performance: GrowGeneration reported a narrower loss of 4 cents per share in Q3 2025, with revenues of $47 million, a 5.6% decline year-over-year, but exceeding estimates. The company improved its gross profit and reduced operating expenses significantly.
Bunge Global SA Earnings Report: Bunge Global reported adjusted earnings of $2.27 per share for Q3 2025, beating estimates despite a 1% year-over-year decline. However, its net revenues surged 71.6% to $22.16 billion but fell short of consensus expectations.
Upcoming Reports from Hydrofarm and BrightView: Hydrofarm is expected to report a revenue decline of 18.8% for Q3 2025, with an anticipated loss of $3.08 per share. BrightView is set to report a slight revenue decline for Q4 2025, with expected earnings of 32 cents per share.
Investment Insights: The article suggests that lesser-known AI firms may offer more lucrative investment opportunities compared to well-known stocks, highlighting the potential for significant profits in the evolving AI landscape.
